0001824034-25-000002.txt : 20251030 0001824034-25-000002.hdr.sgml : 20251030 20251030144403 ACCESSION NUMBER: 0001824034-25-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251030 DATE AS OF CHANGE: 20251030 EFFECTIVENESS DATE: 20251030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Avicenna Biosciences, Inc. CENTRAL INDEX KEY: 0001824034 ORGANIZATION NAME: EIN: 851962440 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-463082 FILM NUMBER: 251434416 BUSINESS ADDRESS: STREET 1: 101 W. CHAPEL HILL STREET, SUITE 210 CITY: DURHAM STATE: NC ZIP: 27701 BUSINESS PHONE: 919-667-2504 MAIL ADDRESS: STREET 1: 101 W. CHAPEL HILL STREET, SUITE 210 CITY: DURHAM STATE: NC ZIP: 27701 D/A 1 primary_doc.xml X0708 D/A LIVE 0001824034 Avicenna Biosciences, Inc. 101 W. CHAPEL HILL STREET, SUITE 210 DURHAM NC NORTH CAROLINA 27701 919-667-2504 DELAWARE None None Corporation true Christopher Meldrum c/o Avicenna Biosciences, Inc. 101 W. CHAPEL HILL STREET, SUITE 210 Durham NC NORTH CAROLINA 27701 Executive Officer Director Thomas Kaiser c/o Avicenna Biosciences, Inc. 101 W. CHAPEL HILL STREET, SUITE 210 Durham NC NORTH CAROLINA 27701 Executive Officer Director Pieter Burger c/o Avicenna Biosciences, Inc. 101 W. CHAPEL HILL STREET, SUITE 210 Durham NC NORTH CAROLINA 27701 Executive Officer Director John Hamer c/o Avicenna Biosciences, Inc. 101 W. CHAPEL HILL STREET, SUITE 210 Durham NC NORTH CAROLINA 27701 Director Dennis Langer c/o Avicenna Biosciences, Inc. 101 W. CHAPEL HILL STREET, SUITE 210 Durham NC NORTH CAROLINA 27701 Director Biotechnology Decline to Disclose 06b true 0001824034-23-000001 2022-02-17 true true true false 0 70650 70650 0 false 1 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false Avicenna Biosciences, Inc. /s/ Christopher Meldrum Christopher Meldrum President 2025-10-28